Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Renal failure and vitamin D].

Alex J Brown1, Adriana S Dusso, Eduardo Slatopolsky

  • 1Washington University School of Medicine.

Clinical Calcium
|March 19, 2005
PubMed
Summary

New vitamin D analogues offer safer control of secondary hyperparathyroidism in chronic kidney disease patients. These compounds effectively suppress parathyroid hormone with reduced risk of high calcium and phosphate levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tailored Catalytic Microenvironments Enable Efficient Electrochemical Ammonia Production.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Current Controversies on Adequate Circulating Vitamin D Levels in CKD.

International journal of molecular sciences·2026
Same author

Non-Invasive Assessment of Vascular Damage Through Pulse Wave Velocity and Superb Microvascular Imaging in Pre-Dialysis Patients.

Biomedicines·2025
Same author

The effect of vitamin D supplementation on mental and functional health outcomes in African Americans with type 2 diabetes.

The Journal of steroid biochemistry and molecular biology·2025
Same author

Synthesis, Structure, and Properties of 2O-BaPtO<sub>3</sub>, a Phase Derived from Hexagonal Perovskite.

Inorganic chemistry·2024
Same author

A rotating white dwarf shows different compositions on its opposite faces.

Nature·2023

Area of Science:

  • Endocrinology
  • Nephrology
  • Pharmacology

Context:

  • Secondary hyperparathyroidism (2HPT) is a common complication in chronic renal failure.
  • Traditional vitamin D therapies like calcitriol can cause hypercalcemia and hyperphosphatemia.

Purpose:

  • To review vitamin D analogues with reduced calcemic activity for managing 2HPT.
  • To explore the mechanisms behind the selective action of these analogues on parathyroid glands.

Summary:

  • Several vitamin D analogues, including 19-nor D(2), 1alphaOHD(2), 22-oxacalcitriol (OCT), and falecalcitriol, show promise in treating 2HPT.
  • Animal studies indicate OCT and 19-nor D(2) have a wider therapeutic window due to lower calcemic activity.
  • Potential mechanisms for reduced toxicity involve altered metabolism and clearance rates.

Impact:

  • These analogues offer a safer and more effective approach to controlling 2HPT in patients with chronic kidney disease.
  • Understanding their molecular basis may lead to the development of even more targeted therapies.

Related Experiment Videos